Merck also sells an antibiotic called Zerbaxa (ceftolozane and tazobactam) for cUTI and cIAI, that it acquired along with Cubist Pharma almost six years ago in a $9.5 billion deal. A landmark ...

Equities researchers at StockNews.com assumed coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a report issued on Sunday. The brokerage set a “hold” rating on the ...

Search for a state or federal candidate to see the donors and industries that support them.

Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat Ratings reports. Nine ...

Our experience confirms and extends the findings of a previous case series on the use of daptomycin for the treatment of VRE UTIs. The previous study [12] of 5 hospitalized patients with ...

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

14 days Prescribing information Etanercept powder Enbrel (Immunex Corporation [Amgen and Wyeth Pharmaceuticals]) 7 days Manufacturer Etanercept prefilled syringe Enbrel (Immunex Corporation [Amgen ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.